Research suggests that Manuka honey may have potential as a supportive agent against Helicobacter pylori through several proposed mechanisms, including direct antibacterial activity and the ability to reduce H. pylori-associated inflammation. The available evidence comes entirely from laboratory-based studies — including cell culture experiments and enzyme inhibition assays — rather than clinical trials in humans, which is an important limitation to keep in mind. Studies indicate that Manuka honey can inhibit H. pylori bacterial growth at levels broadly comparable to a standard antibiotic in lab settings, suppress the release of inflammatory signaling proteins from infected cells, and partially inhibit urease, an enzyme H. pylori uses to survive in the stomach. While these findings are consistently supportive in direction, the research remains at an early, preclinical stage, and no human trials are included in the current evidence base, meaning it is not yet known whether these laboratory effects translate into meaningful outcomes in people with H. pylori infection.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Using food to reduce H. pylori-associated inflammation. | Other | 2012 | Supports | 72 |
| In vitro assessment of Helicobacter pylori ureases inhibition by honey fracti... | Other | 2014 | Supports | 67 |
| Prevalence of Histological Gastritis in a Community Population and Associatio... | Other | 2024 | Neutral | 62 |
| In-vitro antimicrobial activity of selected honeys on clinical isolates of He... | Other | 2007 | Supports | 57 |